Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) CFO Sells $10,328.00 in Stock

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) CFO Molly Henderson sold 1,291 shares of Phathom Pharmaceuticals stock in a transaction that occurred on Thursday, December 19th. The shares were sold at an average price of $8.00, for a total transaction of $10,328.00. Following the transaction, the chief financial officer now directly owns 98,156 shares […]

Leave a Reply

Your email address will not be published.

Previous post Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Average Price Target from Analysts
Next post Lucas: How will the Hamas hostage crisis play out as Biden leaves and Trump takes over